Development of multiplex rt-PCR assays for rapid detection and subtyping of influenza type A viruses from clinical specimens.

College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea.
Journal of Microbiology and Biotechnology (Impact Factor: 1.32). 07/2008; 18(6):1164-9.
Source: PubMed

ABSTRACT We developed multiplex RT-PCR assays that can detect and identify 12 hemagglutinin (H1-H12) and 9 neuraminidase (N1-N9) subtypes that are commonly isolated from avian, swine, and human influenza A viruses. RT-PCR products with unique sizes characteristic of each subtype were amplified by multiplex RT-PCRs, and sequence analysis of each amplicon was demonstrated to be specific for each subtype with 24 reference viruses. The specificity was demonstrated further with DNA or cDNA templates from 7 viruses, 5 bacteria, and 50 influenza A virus negative specimens. Furthermore, the assays could detect and subtype up to 105 dilution of each of the reference viruses that had an original infectivity titer of 106 EID50/ml. Of 188 virus isolates, the multiplex RT-PCR results agreed completely with individual RT-PCR subtyping results and with results obtained from virus isolations. Furthermore, the multiplex RT-PCR methods efficiently detected mixed infections with at least two different subtypes of influenza viruses in one host. Therefore, these methods could facilitate rapid and accurate subtyping of influenza A viruses directly from field specimens.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We designed a degenerate primer set that yielded full-length amplification of hemagglutinin (HA), neuraminidase (NA), matrix (M), and non-structural protein (NSP) genes of influenza A viruses in a single reaction mixture. These four genes were amplified from 15 HA (1-15) and 9 NA (1-9) subtypes of influenza A viruses of avian (n=16) origin. In addition, 272 field isolates of avian origin were tested by this method. Full-length amplification of HA, NA, M, and NSP genes was obtained in 242 (88.9%), 254 (93.4%), 268 (98.5%), and 268 (98.5%) isolates, respectively. No gene was amplified in four isolates. Of these four isolates, two were subtyped as H4N6, one as H7N7, and one as H10N7. Amplification was successful for all 4 genes of H1N1, H2N3, and H3N2 isolates of swine influenza. Also, all four genes were amplified in one equine influenza (H3N8) isolate and seven isolates of human origin (H1N1 and H3N2). This appears to be the first study using degenerate primer set for full-length amplification of four genes of influenza A viruses in a single reaction. Further studies are needed to determine if this primer set can be used for subtyping of influenza virus isolates.
    Journal of virological methods 06/2009; 160(1-2):163-6. DOI:10.1016/j.jviromet.2009.05.003 · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: La situation au Vietnam est favorable aux réassortiments de virus influenza de souches humaines, porcines et aviaires chez le porc du fait du grand nombre de petits élevages multi-espèces, observant un faible niveau de biosécurité. Afin d’étudier la transmission interspécifique porc-volaille, une enquête transversale et une surveillance des maladies respiratoires porcines ont été mises en place pour estimer la viroprévalence de l’influenza porcin, identifier les facteurs de risque, et isoler du virus. Tous les tests RRT-PCR sur écouvillons porcins et aviaires des 93 élevages enquêtés ont été négatifs. La viroprévalence maximale estimée pour l’échantillon, sur WinEpiscope®, est de 4% avec un degré de confiance de 95%. La place des maladies respiratoires porcines dans les élevages a été évaluée grâce aux questionnaires. Des propositions ont été émises concernant les protocoles de surveillance des maladies respiratoires porcines, d’études en abattoir, et d’études cinétiques ciblées.
  • [Show abstract] [Hide abstract]
    ABSTRACT: A novel strain of influenza A (H1N1) virus was isolated in Mexico and the US in March and April 2009. This novel virus spread to many countries and regions in a few months, and WHO raised the level of pandemic alert from phase 5 to phase 6 on June 11, 2009. The accurate identification of H1N1 virus and other human seasonal influenza A viruses is very important for further treatment and control of their infections. In this study, we developed an oligonucleotide microarray to subtype human H1N1, H3N2 and H5N1 influenza viruses, which could distinguish the novel H1N1 from human seasonal H1N1 influenza viruses and swine H1N1 influenza viruses. The microarray utilizes a panel of primers for multiplex PCR amplification of the hemagglutinin (HA), neuraminidase (NA) and matrix (MP) genes of human influenza A viruses. The 59-mer oligonucleotides were designed to distinguish different subtypes of human influenza A viruses. With this microarray, we accurately identified and correctly subtyped the reference virus strains. Moreover, we confirmed 4 out of 39 clinical throat swab specimens from suspected cases of novel H1N1.
    Archives of Virology 12/2009; 155(1):55-61. DOI:10.1007/s00705-009-0545-z · 2.28 Impact Factor


Available from